Tumor endothelial markers: new targets for cancer therapy.
about
Crystal structure of a complex between anthrax toxin and its host cell receptorNear IR heptamethine cyanine dye-mediated cancer imagingHigh expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcomaMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesBiomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective CandidatesBlocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growthThe cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeletonIdentification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivoIdentification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cellsExpression profile of tumor endothelial marker 7 and a putative ligand in the rat spinal cord and dorsal root ganglionA combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivoTumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.Tumor endothelial marker 8 amplifies canonical Wnt signaling in blood vesselsAnthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis.Viral nanoparticles as platforms for next-generation therapeutics and imaging devicesA FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 proteinTumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumorsImaging tumor endothelial marker 8 using an 18F-labeled peptide.Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy.Molecular markers that predict response to colon cancer therapy.Prognostic value of tumour endothelial markers in patients with endometrial cancer.Endocytic uptake pathways utilized by CPMV nanoparticles.Ovarian cancer vaccine trials and tribulations.Genomics and proteomics approaches in understanding tumor angiogenesis.A novel model for evaluating therapies targeting human tumor vasculature and human cancer stem-like cellsClinical biomarkers of angiogenesis inhibition.Large-scale investigation of Leishmania interaction networks with host extracellular matrix by surface plasmon resonance imaging.Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine.Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.Altered angiogenesis in the tumor microenvironment.Targeting angiogenesis and the tumor microenvironment.Tumor angiogenesis--characteristics of tumor endothelial cells.Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer.miRNAs: micro-managers of anticancer combination therapies.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging.RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells.Prognostic values of tumor endothelial markers in patients with colorectal cancer.Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study.
P2860
Q24298884-447108BE-6ACC-49CD-B476-5413171D6435Q24616262-1A718B44-5A19-488D-A9E5-60E5BD86C763Q24681915-211C4928-F0F0-4B55-B139-0B03E3057355Q27011598-ABB1E16A-A695-4891-AB1C-6C928D95BFA4Q28071510-CCBB2327-9FE4-49C7-A57A-B571F5F02B03Q28116133-F0F8924A-845D-4964-9C08-852BCE3066A0Q28116193-A231B176-0120-4C73-802B-93FE65CD8C44Q28566811-41AA51D5-C732-4213-BCB0-F15FB9786346Q28650438-56AB9C1E-9E55-457F-9318-B17D0A331821Q29347113-69F932A0-2A26-42BB-A50D-FABC9BDF3631Q33576606-30AD345A-5296-4259-ACF5-C499D8E917EFQ33746121-21CCAC0D-A4F1-4807-8573-068F7D3BF4C0Q33988361-7D70D06E-832B-4443-8805-318B8A466C30Q34128041-B67CB7B6-263C-4164-A47D-FD555F3A913CQ34168677-342BE857-7E10-40A4-871D-E507F3CB34CBQ34328401-9BB76670-2062-4F88-8D5F-62B939B63D34Q34480359-0C9B08F8-B6BA-475C-981E-98C5A738393DQ35436076-61BCCF90-3EB1-43A8-8E4D-156147137C87Q35985908-EA8986C3-B59F-4E74-83FD-69C8B565A7BFQ36007486-FAC464C2-4F83-42ED-A00F-A83286BB81C1Q36150356-804BBAF4-AE42-49D2-A4E9-CB6F17F8F2BAQ36216815-551E50DB-6087-4BA5-9901-AE83FDE1EE2FQ36662073-E2E12D69-E3E9-4CFA-A8E8-BF23D287B3ADQ36675457-2DCECD12-ADD0-47A2-9013-03B0A9B5BFD7Q36748498-C0CE2F72-CAE7-445C-A459-CFD3A893F173Q36941102-A5765AF8-F140-4033-82C3-2378FCCCA6B2Q37139413-0EA8087F-BEFA-404A-B356-2169392589BDQ37546467-E33E5189-5785-4281-9F8F-570E5FE67FBEQ37562355-CD2EB546-4A19-4A5A-A9C7-82E608F62F95Q37721844-06AA518C-B17A-4AE8-871C-CFD16BD3D213Q37949667-C1B5FD3C-2246-4239-BBDE-DDDAA7262765Q38135123-8BC71D00-1BBD-4CF7-A7AA-C3796A0ACE95Q38734664-6B3DEA01-E449-4BF1-9445-A3C86B0FFDCAQ38832323-73B3EC83-F4D6-4203-9365-595B6F93DC77Q39285150-1516BAD4-3B53-488C-B052-50034387C5D1Q39368829-DDA3D2B4-0BE9-4A0C-8A83-DF19B7D86616Q39444594-869B8B07-FB86-47D3-9118-58EA89EE727BQ39584202-A5825322-7AE5-4B92-B7CA-FBB55B1C8419Q43048459-458F3DDF-433A-4A2C-8865-54C1671BFD59Q48063073-A1E5DC41-3409-466C-AEDB-A5D6F1145C68
P2860
Tumor endothelial markers: new targets for cancer therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tumor endothelial markers: new targets for cancer therapy.
@ast
Tumor endothelial markers: new targets for cancer therapy.
@en
type
label
Tumor endothelial markers: new targets for cancer therapy.
@ast
Tumor endothelial markers: new targets for cancer therapy.
@en
prefLabel
Tumor endothelial markers: new targets for cancer therapy.
@ast
Tumor endothelial markers: new targets for cancer therapy.
@en
P1476
Tumor endothelial markers: new targets for cancer therapy.
@en
P2093
Akash Nanda
Brad St Croix
P356
10.1097/00001622-200401000-00009
P577
2004-01-01T00:00:00Z